The European Pharmacovigilance Working Party, PhVWP, has prepared a recommendation for the wording of the product information for escitalopram-containing medicines.
The Danish Medicines Agency has now translated this recommendation into Danish: Escitalopram (PDF)
The text is used to prepare new product information. Furthermore, marketing authorisation holders of escitalopram-containing medicines must implement the new text by submitting variation applications for all relevant products.